VP8 Mosaic Nanoparticles Elicit Cross-Neutralizing Immune Responses and Provide Protection Against Heterotypic Rotavirus Challenge in Mice
2024 · ACS Nano · 5 citations
https://doi.org/10.1021/acsnano.4c07061
R
Roufang Sheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
17
Citations
3
h-index
0
i10-index
Roufang Sheng is an academic researcher from Xiamen University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research. The author has an h-index of 3, co-authored 51 publications.
ORCID: 0009-0006-3701-3026Papers by this author
worksA single residue switch mediates the broad neutralization of Rotaviruses
2025 · Nature Communications · 4 citations
https://doi.org/10.1038/s41467-025-56114-3
Data from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.c.7311468.v1
Supplementary Fig. S23 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26145117
Supplementary Table S1 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26145084
Supplementary Fig. S8 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26145093
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat